MyAverix Finance
US · Healthcare
Nektar Therapeutics (NKTR)
Biotechnology
Nektar Therapeutics (NKTR) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NKTR
Nektar Therapeutics (NKTR) — FAQ
What is NKTR's P/E ratio?
The price-to-earnings (P/E) ratio for Nektar Therapeutics (NKTR) is 25.00 (data as of 2026-05-23).
Does Nektar Therapeutics pay a dividend?
Dividend yield is not available in the current snapshot for Nektar Therapeutics (NKTR). Check the MyAverix Finance app for the latest dividend data.
What sector is Nektar Therapeutics in?
Nektar Therapeutics (NKTR) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NKTR listed on?
NKTR is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.